Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Chidamide Combination with Chemotherapy As the First-Line Treatment for T-Cell Acute Lymphoblastic Leukemia: A Single-Center Retrospective Study

Mengyao Li, Zi-Yuan Nie, Jinhai Ren, Xiaohong Zhang, Jinao Li, Ying Zhan, Xiaolei Zhang, Xiaoling Guo

Blood (2024) 144 (Supplement 1): 5896.

https://doi.org/10.1182/blood-2024-200460

Published: 2024

Journal Articles

Outcome for Mothers and Neonates Among Pregnant Women with Von Willebrand Disease: A Prospective Nationwide Multicenter Study

Qiusha Huang, Xiaolu Zhu, Yun He, HaiXia Fu, Qi Chen, Peng Zhao, Jin Wu, YingJun Chang, LanPing Xu, Xue Xu, Xiaohong Zhang, Jianliu Wang, Xiaojun Huang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 3703.

https://doi.org/10.1182/blood-2024-205168

Published: 2024

Journal Articles

The Profiling of Circulating Tumor DNA Liquid Biopsy in Children and Adolescent Lymphoblastic Lymphoma

Blood (2022) 140 (Supplement 1): 11876–11877.

https://doi.org/10.1182/blood-2022-165928

Published: 2022

Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase Ⅱ Clinical Trial

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-141752

Published: 2020

Journal Articles

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial

Blood (2019) 134 (Supplement_1): 2838.

https://doi.org/10.1182/blood-2019-126481

Published: 2019

Journal Articles

Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

Blood (2017) 130 (Supplement 1): 5167.

https://doi.org/10.1182/blood.V130.Suppl_1.5167.5167

Published: 2017

Journal Articles

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Blood (2017) 130 (Supplement 1): 5213.

https://doi.org/10.1182/blood.V130.Suppl_1.5213.5213

Published: 2017

Journal Articles

Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell Lymphoma

Blood (2017) 130 (Supplement 1): 5208.

https://doi.org/10.1182/blood.V130.Suppl_1.5208.5208

Published: 2017

Journal Articles

A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma

Blood (2014) 124 (21): 5475.

https://doi.org/10.1182/blood.V124.21.5475.5475

Published: 2014

Journal Articles

CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine

Ying Gu, Ting Chen, Zhipeng Meng, Yichao Gan, Xiaohua Xu, Guiyu Lou, Hongzhi Li, Xiaoxian Gan, Hong Zhou, Jinfen Tang, Genbo Xu, Liansheng Huang, Xiaohong Zhang, Yongming Fang, Kai Wang, Shu Zheng, Wendong Huang, Rongzhen Xu

Blood (2012) 120 (24): 4829–4839.

https://doi.org/10.1182/blood-2012-06-434894

Published: 2012

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Linezolid in Immunocompromised Patients with Hematological Malignancy

Shenxian Qian, MD, Hua Song, MD, Xuejin Zhang, MD, Xuejin Zhang, MD, Xiaohong Zhang, MD, Wenji Luo, MD, Wenji Luo, MD, Qian Huang, MD

Blood (2012) 120 (21): 4838.

https://doi.org/10.1182/blood.V120.21.4838.4838

Published: 2012

Journal Articles

Reevaluation of Factors Leading to the Successful Isolation of Mesenchymal Stem Cells From Human Umbilical Cord Blood and Their Differentiation to Mesenchymal Lineages.

Xiaohong Zhang, MD, PhD, Masako Hirai, BHS., Susana Cantero, MD, Rodica Ciubotariu, MD, PhD, Allen Hirsh, PhD, Hitoshi Satoh, PhD, Izuru Yokomi, PhD, Kotaro Yoshimura, MD, PhD, Toshihide Nishimura, PhD, Satoru Yamaguchi, MD, PhD, Koichi Igura, PhD, Pablo Rubinstein, MD, Tsuneo A. Takahashi, DSc

Blood (2009) 114 (22): 3232.

https://doi.org/10.1182/blood.V114.22.3232.3232

Published: 2009

Journal Articles

Roles of Phosphorylated p210bcr/abl and Hsp90 Protein in Apoptosis Induced by Berbamine in K562 Cells.

Xiaohong Zhang, Jianrong Sun, Rongzhen Xu, Zhiwen He, Yin Gu

Blood (2006) 108 (11): 4418.

https://doi.org/10.1182/blood.V108.11.4418.4418

Published: 2006

Journal Articles

Increased Fatty Acid Synthase Is a Therapeutic Target in Multiple Myeloma.

Weiqin Wang, PhD, Xiaoying Zhao, MD, Haiyan Wang, Gengbo Xu, Xiaohong Zhang

Blood (2006) 108 (11): 5084.

https://doi.org/10.1182/blood.V108.11.5084.5084

Published: 2006

Journal Articles

Significance and Study of Fibrinolytic System in Pleural and Ascitic Fluid.

Xingguo Lu, Jianshan Mao Mao, Jin Liu, Xiaohong Zhang, Xiaoying Zhao, Genbo Xu, Xubo Gong, Zhongguo Yang

Blood (2005) 106 (11): 4070.

https://doi.org/10.1182/blood.V106.11.4070.4070

Published: 2005

Journal Articles

Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia

Rongzhen Xu, Yingzi Yu, Shu Zheng, Xiaoying Zhao, Qinghua Dong, Zhiwen He, Yun Liang, Qinghua Lu, Yongmin Fang, Xiaoxian Gan, Xiaohua Xu, Suzhan Zhang, Qi Dong, Xiaohong Zhang, Gen-Sheng Feng

Blood (2005) 106 (9): 3142–3149.

https://doi.org/10.1182/blood-2004-10-4057

Published: 2005

Journal Articles

Mechanism of Arsenic Trioxide-Induced Apoptosis on Multiple Myeloma Cells.

Xiaohong Zhang, M.D., Yun Liang, M.D., Lida Su, M.D.

Blood (2004) 104 (11): 4904.

https://doi.org/10.1182/blood.V104.11.4904.4904

Published: 2004

Journal Articles

Detection and Clinical Significance of Thrombomodulin in Both Plasma and Tissue Extracts of Cancer Patients.

Xiaohua Xu, Liansheng Huang, Xingguo Lu, Xiaohong Zhang, Xiaoying Zhao

Blood (2004) 104 (11): 3966.

https://doi.org/10.1182/blood.V104.11.3966.3966

Published: 2004

Journal Articles

SHP-2 Tyrosine Phosphatase Directly Controls the Proliferative Potential of Neoplasm Cells of Human Leukemia.

Rongzhen Xu, Ph.D, Yingzi Yu, Xiaoying Zhao, Zhiwen He, Yun Liang, Xiaohong Zhang

Blood (2004) 104 (11): 4286.

https://doi.org/10.1182/blood.V104.11.4286.4286

Published: 2004

Journal Articles

Immortalized Human Placenta Derived Mesenchymal Cells by Transfection with Bmi-1 Lost the Abilitiy To Differencitate into Cell Types of Osteocytic, Condoricytic and Neural Lineages.

Xiaohong Zhang, MD.PhD, Yasushi Soda, MD.PhD, Kenji Takahashi, PhD, Yuansong Bai, MD.PhD, Koichi Igura, PhD, Ayako Mitsuru, Arinobu Tojo, MD.PhD, Tsuneo A. Takahashi, PhD

Blood (2004) 104 (11): 4259.

https://doi.org/10.1182/blood.V104.11.4259.4259

Published: 2004

NARROW

Chidamide Combination with Chemotherapy As the First-Line Treatment for T-Cell Acute Lymphoblastic Leukemia: A Single-Center Retrospective Study

Outcome for Mothers and Neonates Among Pregnant Women with Von Willebrand Disease: A Prospective Nationwide Multicenter Study

The Profiling of Circulating Tumor DNA Liquid Biopsy in Children and Adolescent Lymphoblastic Lymphoma

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Prospective, Single-Arm, Open-Label, Multi-Center, Phase Ⅱ Clinical Trial

Safety and Efficacy of Mitoxantrone Hydrochloride Liposome in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma and Extranodal NK/T-Cell Lymphoma: A Multicenter, Single-Arm, Open-Label, Phase 2 Clinical Trial

Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Three-Year Follow-up on Safety and Effectiveness of Rituximab Plus Chemotherapy As First-Line Treatment of Diffuse Large B-Cell Lymphoma

A Prospective, Observational Study on the Safety and Effectiveness of Rituximab Plus Chemotherapy As the First-Line Treatment of Diffuse Large B-Cell Lymphoma

CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine

Efficacy and Safety of Linezolid in Immunocompromised Patients with Hematological Malignancy

Reevaluation of Factors Leading to the Successful Isolation of Mesenchymal Stem Cells From Human Umbilical Cord Blood and Their Differentiation to Mesenchymal Lineages.

Roles of Phosphorylated p210bcr/abl and Hsp90 Protein in Apoptosis Induced by Berbamine in K562 Cells.

Increased Fatty Acid Synthase Is a Therapeutic Target in Multiple Myeloma.

Significance and Study of Fibrinolytic System in Pleural and Ascitic Fluid.

Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia

Mechanism of Arsenic Trioxide-Induced Apoptosis on Multiple Myeloma Cells.

Detection and Clinical Significance of Thrombomodulin in Both Plasma and Tissue Extracts of Cancer Patients.

SHP-2 Tyrosine Phosphatase Directly Controls the Proliferative Potential of Neoplasm Cells of Human Leukemia.

Immortalized Human Placenta Derived Mesenchymal Cells by Transfection with Bmi-1 Lost the Abilitiy To Differencitate into Cell Types of Osteocytic, Condoricytic and Neural Lineages.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only